Company Overview
American HealthCare Capital is pleased to exclusively introduce a full service medical laboratory for sale based in southeast Florida with a focus on introducing innovative diagnostics for physicians, clinics, and pharmaceutical clients. The company was formed in 2021. Services offered include Nasal Swab/Molecular (Covid, Influenza A&B, RSV, and hMPV), Blood (Chemistry, Immunology, and Hematology), and Urine (Urinalysis, such as Microscopic and Pregnancy). The lab is both CLIA and COLA certified.
Financial Overview
Reimbursement is 50% through insurance, including commercial insurance, Medicare, and Medicaid, and 50% is cash (patient pay). In 2022, which was their first full year of operation, the company’s Gross Revenue was $6,541,440 with a Net Operating Income of $1,668,186 (26%). In 2023, they saw a sharp decline in revenue, which was largely attributed to a decrease in COVID testing demand, as well as the significant expense and time associated with validating the lab equipment for new tests. They grossed $1.8 million in 2023 with a net loss, and they are currently operating at a minimum in anticipation of selling. However, the seller feels there is room for expansion with a new owner who is motivated to grow the business.
Staff Overview
The staff could be available to stay on if desired. The owner would like to pursue other business opportunities but will assist during a transitional period.
Asking Price
The asking price for this turnkey lab opportunity is $490,000, which includes all the lab equipment.
